Titan Bio-Tech [TITANBIO] vs Zota Health Care [ZOTA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Titan Bio-Tech Ltd. wins in 13 metrics, Zota Health Care Limited wins in 5 metrics, with 0 ties. Titan Bio-Tech Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Titan Bio-Tech Ltd. | Zota Health Care Limited | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 74.64 | -62.53 | Titan Bio-Tech Ltd. |
| Price-to-Book Ratio | 12.19 | 12.61 | Titan Bio-Tech Ltd. |
| Debt-to-Equity Ratio | 5.32 | 56.90 | Titan Bio-Tech Ltd. |
| PEG Ratio | -1.22 | -0.59 | Zota Health Care Limited |
| EV/EBITDA | 61.34 | -126.59 | Titan Bio-Tech Ltd. |
| Profit Margin (TTM) | 14.13% | -15.37% | Titan Bio-Tech Ltd. |
| Operating Margin (TTM) | 16.92% | -15.88% | Titan Bio-Tech Ltd. |
| EBITDA Margin (TTM) | 16.92% | N/A | N/A |
| Return on Equity | 14.04% | -24.83% | Titan Bio-Tech Ltd. |
| Return on Assets (TTM) | 12.32% | -12.84% | Titan Bio-Tech Ltd. |
| Free Cash Flow (TTM) | $106.79M | $-959.42M | Titan Bio-Tech Ltd. |
| Dividend Yield | 0.42% | 0.07% | Titan Bio-Tech Ltd. |
| 1-Year Return | 419.45% | 27.17% | Titan Bio-Tech Ltd. |
| Price-to-Sales Ratio (TTM) | 10.54 | 8.34 | Zota Health Care Limited |
| Enterprise Value | $20.35B | $45.66B | Zota Health Care Limited |
| EV/Revenue Ratio | 10.57 | 9.66 | Zota Health Care Limited |
| Gross Profit Margin (TTM) | N/A | 60.28% | N/A |
| Revenue per Share (TTM) | $47 | $157 | Zota Health Care Limited |
| Earnings per Share (Diluted) | $6.58 | $-23.94 | Titan Bio-Tech Ltd. |
| Beta (Stock Volatility) | -0.48 | 0.36 | Titan Bio-Tech Ltd. |
Titan Bio-Tech Ltd. vs Zota Health Care Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Titan Bio-Tech Ltd. | 0.80% | 3.09% | -1.02% | 28.03% | 96.24% | 110.92% |
| Zota Health Care Limited | 1.75% | 3.68% | 3.22% | 14.06% | -26.10% | -17.99% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Titan Bio-Tech Ltd. | 419.45% | 756.94% | 499.88% | 6,742.31% | 9,962.22% | 20,395.39% |
| Zota Health Care Limited | 27.17% | 243.00% | 632.12% | 1,248.00% | 1,248.00% | 1,248.00% |
Performance & Financial Health Analysis: Titan Bio-Tech Ltd. vs Zota Health Care Limited
| Metric | TITANBIO | ZOTA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹19.90B | ₹39.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 68,890 | 56,411 |
| 90 Day Avg. Volume | 156,601 | 53,265 |
| Last Close | ₹448.30 | ₹1,246.70 |
| 52 Week Range | ₹74.73 - ₹555.65 | ₹917.20 - ₹1,740.00 |
| % from 52W High | -19.32% | -28.35% |
| All-Time High | ₹1,460.00 (Feb 18, 2026) | ₹1,740.00 (Nov 21, 2025) |
| % from All-Time High | -69.29% | -28.35% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.48% | 0.98% |
| Quarterly Earnings Growth | 0.94% | 1.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | -0.15% |
| Operating Margin (TTM) | 0.17% | -0.16% |
| Return on Equity (TTM) | 0.14% | -0.25% |
| Debt to Equity (MRQ) | 5.32 | 56.90 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹40.29 | ₹103.04 |
| Cash per Share (MRQ) | ₹0.87 | ₹1.87 |
| Operating Cash Flow (TTM) | ₹197.75M | ₹-1,007,999,000 |
| Levered Free Cash Flow (TTM) | ₹215.32M | ₹-563,984,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.42% | 0.07% |
| Last 12-Month Dividend | ₹4.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Titan Bio-Tech Ltd. vs Zota Health Care Limited
| Metric | TITANBIO (Apr 24, 2026) | ZOTA (Apr 22, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 74.64 | -62.53 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -1.22 | -0.59 |
| Price to Sales (TTM) | 10.54 | 8.34 |
| Price to Book (MRQ) | 12.19 | 12.61 |
| Market Capitalization | ||
| Market Capitalization | ₹19.90B | ₹39.41B |
| Enterprise Value | ₹20.35B | ₹45.66B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 10.57 | 9.66 |
| Enterprise to EBITDA | 61.34 | -126.59 |
| Risk & Other Metrics | ||
| Beta | -0.48 | 0.36 |
| Book Value per Share (MRQ) | ₹40.29 | ₹103.04 |
Financial Statements Comparison: Titan Bio-Tech Ltd. vs Zota Health Care Limited
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | TITANBIO (2025) | ZOTA (2025) |
|---|---|---|
| Revenue/Sales | 1.56B | 2.93B |
| Cost of Goods Sold | 892.53M | 1.44B |
| COGS % of Revenue | 57.0% | 49.0% |
| Gross Profit | 671.98M | 1.49B |
| Gross Margin | 43.0% | 51.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 212.57M | -480.90M |
| Operating Margin | 13.6% | -16.4% |
| EBITDA | 285.61M | -42.20M |
| EBITDA Margin | 18.3% | -1.4% |
| Pre-Tax Income | 243.67M | -576.44M |
| Pre-Tax Income % of Revenue | 15.6% | -19.7% |
| Income Tax | 60.96M | -9.06M |
| Income Tax % of Revenue | 3.9% | -0.3% |
| Net Income (Profit) | 215.32M | -567.39M |
| Profit Margin | 13.8% | -19.4% |
Balance Sheet & Liquidity Metrics
| Metric | TITANBIO (2025) | ZOTA (2025) |
|---|---|---|
| Cash & Equivalents | 51.28M | 21.32M |
| Total Current Assets | 790.38M | 1.84B |
| Total Current Assets % of Revenue | 50.5% | 62.9% |
| Total Current Liabilities | 177.36M | 1.01B |
| Total Current Liabilities % of Revenue | 11.3% | 34.3% |
| Long-Term Debt | 4.19M | 1.08B |
| Long-Term Debt % of Revenue | 0.3% | 36.7% |
| Total Shareholders Equity | 1.53B | 2.27B |
| Retained Earnings | 1.36B | -191.89M |
| Retained Earnings % of Revenue | 87.0% | -6.5% |
| Property, Plant & Equipment | 571.62M | 65.25M |
Cash Flow Statement Comparison
| Metric | TITANBIO (2025) | ZOTA (2025) |
|---|---|---|
| Operating Cash Flow | 197.75M | -1.01B |
| Operating Cash Flow % of Revenue | 12.6% | -34.4% |
| Capital Expenditures | -85.26M | -459.67M |
| Free Cash Flow | 106.79M | -959.42M |
| FCF Margin | 6.8% | -32.7% |
| Debt Repayment | -2.69M | -140.67M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TITANBIO | ZOTA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 41.32M | 30.33M |
| Float Shares | 13.13M | 15.02M |
| % Held by Insiders | 68.21% | 0.00% |
| % Held by Institutions | 0.00% | 1.16% |
| % Held by Public | 31.79% | 98.84% |
Dividend Analysis & Yield Comparison: Titan Bio-Tech Ltd. vs Zota Health Care Limited
| Metric | TITANBIO | ZOTA |
|---|---|---|
| Last 12-Month Dividend | ₹4.00 | ₹1.00 |
| Last 12-Month Dividend Yield | 0.42% | 0.07% |
| 3-Year Avg Annual Dividend | ₹1.93 | ₹1.00 |
| 3-Year Avg Dividend Yield | 0.34% | 0.16% |
| 3-Year Total Dividends | ₹5.80 | ₹3.00 |
| Ex-Dividend Date | Sep 19, 2025 | Sep 22, 2025 |